Your browser is no longer supported. Please, upgrade your browser.
Insulet Corporation
Index- P/E1704.70 EPS (ttm)0.13 Insider Own0.30% Shs Outstand66.11M Perf Week0.74%
Market Cap14.72B Forward P/E149.11 EPS next Y1.53 Insider Trans-14.17% Shs Float65.97M Perf Month-23.09%
Income8.90M PEG- EPS next Q0.14 Inst Own98.50% Short Float3.56% Perf Quarter-19.06%
Sales958.70M P/S15.36 EPS this Y-44.60% Inst Trans0.64% Short Ratio4.14 Perf Half Y-12.36%
Book/sh8.85 P/B25.81 EPS next Y111.89% ROA0.50% Target Price287.19 Perf Year11.99%
Cash/sh13.15 P/C17.37 EPS next 5Y- ROE1.50% 52W Range164.40 - 306.46 Perf YTD-10.64%
Dividend- P/FCF- EPS past 5Y15.90% ROI2.90% 52W High-21.53% Beta0.73
Dividend %- Quick Ratio5.50 Sales past 5Y27.90% Gross Margin65.00% 52W Low46.28% ATR11.75
Employees1900 Current Ratio6.40 Sales Q/Q27.40% Oper. Margin6.30% RSI (14)39.64 Volatility5.35% 4.70%
OptionableYes Debt/Eq1.82 EPS Q/Q100.00% Profit Margin0.90% Rel Volume1.00 Prev Close228.43
ShortableYes LT Debt/Eq1.80 EarningsMay 06 AMC Payout0.00% Avg Volume567.58K Price240.49
Recom2.20 SMA20-9.69% SMA50-10.23% SMA200-4.17% Volume397,777 Change5.28%
Apr-01-21Upgrade SVB Leerink Mkt Perform → Outperform $275 → $320
Mar-19-21Upgrade Canaccord Genuity Hold → Buy $280
Jan-29-21Downgrade Piper Sandler Overweight → Neutral $260
Dec-16-20Downgrade Citigroup Buy → Neutral $255 → $268
Jul-28-20Initiated Wells Fargo Overweight $231
Apr-24-20Downgrade SVB Leerink Outperform → Mkt Perform
Apr-03-20Initiated BofA/Merrill Neutral $200
Mar-31-20Downgrade Berenberg Buy → Hold
Mar-05-20Initiated Citigroup Buy $220
Dec-10-19Initiated CFRA Sell $163
Oct-23-19Initiated Stifel Hold
Oct-18-19Downgrade Canaccord Genuity Buy → Hold $135 → $145
Oct-14-19Downgrade BTIG Research Buy → Neutral
Oct-04-19Downgrade UBS Buy → Neutral $155 → $160
Oct-03-19Downgrade Guggenheim Buy → Neutral
Aug-06-19Upgrade JP Morgan Neutral → Overweight $120 → $155
Jun-10-19Downgrade Northland Capital Outperform → Market Perform
May-06-19Upgrade BTIG Research Neutral → Buy $115
Apr-20-18Initiated Berenberg Buy $100
Feb-22-18Reiterated Barclays Overweight $85 → $90
May-10-21 05:35PM  
May-07-21 09:04AM  
May-06-21 05:15PM  
May-04-21 06:00AM  
May-03-21 06:00AM  
Apr-29-21 04:01PM  
Apr-19-21 11:10AM  
Apr-12-21 06:56AM  
Apr-05-21 06:00AM  
Mar-29-21 04:11PM  
Mar-25-21 11:30AM  
Mar-22-21 07:14PM  
Mar-20-21 11:45AM  
Mar-19-21 04:20PM  
Mar-16-21 04:01PM  
Mar-08-21 08:15AM  
Feb-24-21 04:11PM  
Feb-23-21 10:30PM  
Feb-10-21 04:44AM  
Feb-08-21 04:01PM  
Jan-19-21 09:56AM  
Jan-18-21 06:00AM  
Jan-11-21 06:00AM  
Jan-07-21 01:18PM  
Dec-24-20 03:05AM  
Dec-23-20 12:11PM  
Dec-21-20 11:36AM  
Dec-04-20 11:31AM  
Nov-24-20 02:19PM  
Nov-09-20 04:01PM  
Nov-05-20 10:07AM  
Nov-04-20 08:31PM  
Nov-02-20 06:00AM  
Oct-29-20 06:00AM  
Oct-28-20 12:32PM  
Oct-26-20 09:25PM  
Oct-22-20 10:43AM  
Oct-20-20 04:01PM  
Oct-14-20 01:42PM  
Oct-13-20 09:07AM  
Oct-12-20 01:28PM  
Oct-05-20 06:00AM  
Oct-01-20 09:21AM  
Sep-21-20 11:25AM  
Sep-07-20 05:14PM  
Sep-05-20 11:31AM  
Sep-01-20 02:56PM  
Aug-25-20 10:44AM  
Aug-24-20 06:00AM  
Aug-12-20 03:04PM  
Aug-10-20 11:31AM  
Aug-06-20 05:25PM  
Jul-30-20 12:34PM  
Jul-13-20 05:04PM  
Jul-06-20 04:03PM  
Jun-30-20 12:23PM  
Jun-29-20 06:00AM  
Jun-24-20 06:00AM  
Jun-21-20 11:13AM  
Jun-12-20 08:58AM  
Jun-11-20 06:00AM  
Jun-05-20 06:00AM  
Jun-03-20 06:45AM  
May-31-20 10:05PM  
May-28-20 04:01PM  
May-23-20 07:28AM  
May-14-20 03:45PM  
May-12-20 09:26PM  
May-11-20 10:39AM  
May-09-20 01:31PM  
May-08-20 10:55AM  
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, and the Middle East. Insulet Corporation was founded in 2000 and is headquartered in Acton, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Nevinny Corinne HDirectorMay 13Sale231.42933215,9153,350May 14 04:06 PM
Petrovic ShaceyPresident and CEOApr 01Option Exercise30.5815,000458,70056,589Apr 02 06:28 PM
Petrovic ShaceyPresident and CEOApr 01Sale266.1715,0003,992,55041,589Apr 02 06:28 PM
Petrovic ShaceyPresident and CEOJan 04Option Exercise30.5815,000458,70036,535Jan 05 04:37 PM
Petrovic ShaceyPresident and CEOJan 04Sale250.6115,0003,759,15021,535Jan 05 04:37 PM
Petrovic ShaceyPresident and CEODec 18Option Exercise29.263,41799,98122,230Dec 21 04:34 PM
Lemoine David ADirectorNov 17Sale250.711,000250,7106,977Nov 18 04:17 PM
Fallon John A.DirectorNov 04Option Exercise28.873,00086,61017,498Nov 06 04:05 PM
Fallon John A.DirectorNov 04Sale230.003,000690,00014,498Nov 06 04:05 PM
Fallon John A.DirectorNov 02Option Exercise35.114,000140,44018,498Nov 03 04:05 PM
Fallon John A.DirectorNov 02Sale225.004,000900,00014,498Nov 03 04:05 PM
Spears Michael PSVP, RA and ComplianceOct 09Option Exercise29.6322,257659,38331,204Oct 13 04:20 PM
Spears Michael PSVP, RA and ComplianceOct 09Sale246.1022,2575,477,4488,947Oct 13 04:20 PM
Petrovic ShaceyPresident and CEOOct 05Option Exercise30.5815,000458,70033,813Oct 07 04:14 PM
Petrovic ShaceyPresident and CEOOct 05Sale233.9115,0003,508,65018,813Oct 07 04:14 PM
Alpuche CharlesEVP & Chief Operating OfficerSep 01Sale220.113,415751,67641,257Sep 02 04:36 PM
Christensen BretEVP and CCOAug 12Sale201.545,0001,007,70013,700Aug 13 04:36 PM
Benjamin EricSVP, Innovation and StrategyJul 23Option Exercise29.398,392246,61117,096Jul 24 04:24 PM
Benjamin EricSVP, Innovation and StrategyJul 23Sale210.0014,9123,131,5208,704Jul 24 04:24 PM